Annual ROE
-37.40%
+1.66%+4.25%
December 31, 2023
Summary
- As of February 27, 2025, FDMT annual return on equity is -37.40%, with the most recent change of +1.66% (+4.25%) on December 31, 2023.
- During the last 3 years, FDMT annual ROE has risen by +24.42% (+39.50%).
- FDMT annual ROE is now -155.35% below its all-time high of 67.57%, reached on December 31, 2019.
Performance
FDMT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-30.15%
-4.61%-18.05%
September 30, 2024
Summary
- As of February 27, 2025, FDMT quarterly return on equity is -30.15%, with the most recent change of -4.61% (-18.05%) on September 30, 2024.
- Over the past year, FDMT quarterly ROE has increased by +5.21% (+14.73%).
- FDMT quarterly ROE is now -100.81% below its all-time high of 3714.36%, reached on September 30, 2020.
Performance
FDMT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FDMT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.3% | +14.7% |
| 3 y3 years | +39.5% | +14.7% |
| 5 y5 years | -208.0% | +14.7% |
FDMT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.9% | +4.3% | -18.1% | +30.3% |
| 5 y | 5-year | -155.3% | +39.5% | -100.8% | +80.5% |
| alltime | all time | -155.3% | +39.5% | -100.8% | +80.5% |
4D Molecular Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -30.15%(+18.1%) |
| Jun 2024 | - | -25.54%(-13.0%) |
| Mar 2024 | - | -29.34%(-17.8%) |
| Dec 2023 | -37.40%(-4.2%) | -35.69%(+0.9%) |
| Sep 2023 | - | -35.36%(-17.5%) |
| Jun 2023 | - | -42.87%(-0.9%) |
| Mar 2023 | - | -43.24%(+10.2%) |
| Dec 2022 | -39.06%(+57.6%) | -39.22%(+1.7%) |
| Sep 2022 | - | -38.58%(+2.6%) |
| Jun 2022 | - | -37.62%(+22.5%) |
| Mar 2022 | - | -30.72%(+10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -24.78%(-59.9%) | -27.80%(-13.9%) |
| Sep 2021 | - | -32.30%(-9.1%) |
| Jun 2021 | - | -35.55%(-46.2%) |
| Mar 2021 | - | -66.06%(-57.2%) |
| Dec 2020 | -61.82%(-191.5%) | -154.32%(-104.2%) |
| Sep 2020 | - | 3714.36%(+4335.6%) |
| Jun 2020 | - | 83.74%(+5.0%) |
| Mar 2020 | - | 79.72%(+40.1%) |
| Dec 2019 | 67.57%(+95.2%) | 56.89%(+19.2%) |
| Sep 2019 | - | 47.72% |
| Dec 2018 | 34.62%(-39.6%) | - |
| Dec 2017 | 57.29% | - |
FAQ
- What is 4D Molecular Therapeutics annual return on equity?
- What is the all time high annual ROE for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual ROE year-on-year change?
- What is 4D Molecular Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly ROE year-on-year change?
What is 4D Molecular Therapeutics annual return on equity?
The current annual ROE of FDMT is -37.40%
What is the all time high annual ROE for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual return on equity is 67.57%
What is 4D Molecular Therapeutics annual ROE year-on-year change?
Over the past year, FDMT annual return on equity has changed by +1.66% (+4.25%)
What is 4D Molecular Therapeutics quarterly return on equity?
The current quarterly ROE of FDMT is -30.15%
What is the all time high quarterly ROE for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly return on equity is 3714.36%
What is 4D Molecular Therapeutics quarterly ROE year-on-year change?
Over the past year, FDMT quarterly return on equity has changed by +5.21% (+14.73%)